Amgen will eliminate 200 jobs at its plants in Boulder and Longmont. The company cited its decision to stop producing Epogen, a drug used by patients suffering from kidney disease and cancer. About 430 people will continue to work at Amgen's two Boulder C
Back to Search Results
Login or obtain Article Access to read the rest of this content.
- Date:
January 30, 2014
- Category:
Economy - Denver
- January 31, 2014
- Bill James